Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,982 | -160,060 | -154,440 | -129,323 | -76,088 |
| Depreciation Amortization | 483 | 4,375 | 3,570 | 2,911 | 1,334 |
| Accounts receivable | 12,584 | 1,090 | 8,136 | 15,678 | 15,756 |
| Accounts payable and accrued liabilities | 1,727 | -2,888 | -2,330 | 1,231 | -27 |
| Other Working Capital | -1,847 | -31,229 | 1,983 | 12,995 | 17,615 |
| Other Operating Activity | -11,026 | 23,471 | 14,227 | -1,503 | -6,389 |
| Operating Cash Flow | $-23,061 | $-165,241 | $-128,854 | $-98,011 | $-47,799 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 139,006 | 139,006 | 99,000 | 56,501 |
| PPE Investments | 64 | -338 | -396 | 37 | -114 |
| Investing Cash Flow | $64 | $138,668 | $138,610 | $99,037 | $56,387 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 43,342 | 26,016 | 8,847 | 1,435 |
| Other Financing Activity | 0 | -2,872 | -2,872 | -2,872 | -2,872 |
| Financing Cash Flow | $N/A | $40,470 | $23,144 | $5,975 | $-1,437 |
| Beginning Cash Position | 149,315 | 135,418 | 135,418 | 135,418 | 135,418 |
| End Cash Position | 126,318 | 149,315 | 168,318 | 142,419 | 142,569 |
| Net Cash Flow | $-22,997 | $13,897 | $32,900 | $7,001 | $7,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,061 | -165,241 | -128,854 | -98,011 | -47,799 |
| Capital Expenditure | -92 | -607 | -547 | -114 | -114 |
| Free Cash Flow | -23,153 | -165,848 | -129,401 | -98,125 | -47,913 |